{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:03Z","timestamp":1786982343170,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12265-023-10400-x","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:02:05Z","timestamp":1685628125000},"page":"1135-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Rationale of the BIOFLOW-DAPT Trial: a Prospective, Randomized, Multicenter Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination with 1-Month Dual Antiplatelet Therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Antonio","family":"Landi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Wlodarczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"T\u00f6lg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Legutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Lhermusier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Honton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Laurenz","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Stammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Ferdinande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-7110","authenticated-orcid":false,"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the BIOFLOW-DAPT investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"9562","key":"10400_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, J\u00fcni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667\u201378.","journal-title":"Lancet"},{"issue":"12","key":"10400_CR2","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","volume":"48","author":"M Pfisterer","year":"2006","unstructured":"Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48(12):2584\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10400_CR3","first-page":"e574","volume":"124","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. Circulation. 2011;124(23):e574-651.","journal-title":"Circulation"},{"issue":"20","key":"10400_CR4","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501\u201355.","journal-title":"Eur Heart J"},{"issue":"21","key":"10400_CR5","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","volume":"75","author":"D Cao","year":"2020","unstructured":"Cao D, Mehran R, Dangas G, Baber U, Sartori S, Chandiramani R, Stefanini GG, Angiolillo DJ, Capodanno D, Urban P, Morice MC, Krucoff M, Goel R, Roumeliotis A, Sweeny J, Sharma SK, Kini A. Validation of the Academic Research Consortium high bleeding risk definition in contemporary PCI patients. J Am Coll Cardiol. 2020;75(21):2711\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10400_CR6","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","volume":"41","author":"N Corpataux","year":"2020","unstructured":"Corpataux N, Spirito A, Gragnano F, Vaisnora L, Galea R, Svab S, Gargiulo G, Zanchin T, Zanchin C, Siontis GCM, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, R\u00e4ber L, Capodanno D, Urban P, Pocock S, Heg D, Windecker S, Valgimigli M. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk. Eur Heart J. 2020;41(38):3743\u20139.","journal-title":"Eur Heart J"},{"issue":"5","key":"10400_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","volume":"16","author":"Y Ueki","year":"2020","unstructured":"Ueki Y, B\u00e4r S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis GCM, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, R\u00e4ber L. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention. 2020;16(5):371\u20139.","journal-title":"EuroIntervention"},{"issue":"3","key":"10400_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, J\u00fcni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European. Eur Heart J. 2018;39(3):213\u201360.","journal-title":"Eur Heart J"},{"issue":"23","key":"10400_CR9","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","volume":"72","author":"D Capodanno","year":"2018","unstructured":"Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. J Am Coll Cardiol. 2018;72(23):2915\u201331. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.057.","journal-title":"J Am Coll Cardiol"},{"issue":"10096","key":"10400_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(17)31927-X","volume":"390","author":"RA Byrne","year":"2017","unstructured":"Byrne RA, Stone GW, Ormiston J, Kastrati A. Coronary balloon angioplasty, stents, and scaffolds. Lancet. 2017;390(10096):781\u201392.","journal-title":"Lancet"},{"issue":"17","key":"10400_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/eurheartj\/eht570","volume":"35","author":"SH Kang","year":"2014","unstructured":"Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Cohen DJ, Hwang SS, Kim HS. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. Eur Heart J. 2014;35(17):1147\u201358.","journal-title":"Eur Heart J"},{"issue":"23","key":"10400_CR12","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","volume":"65","author":"T Palmerini","year":"2015","unstructured":"Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachojannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2015;65(23):2496\u2013507.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10400_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","volume":"65","author":"M Valgimigli","year":"2015","unstructured":"Valgimigli M, Patialiakas A, Thury A, McFadden E, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Airoldi F, Ferlini M, Liistro F, Dellavalle A, Vranckx P, Briguori C. ZEUS Investigators. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. J Am Coll Cardiol. 2015;65(8):805\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10400_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jcin.2015.11.015","volume":"9","author":"S Ariotti","year":"2016","unstructured":"Ariotti S, Adamo M, Costa F, Patialiakas A, Briguori C, Thury A, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Ferlini M, Vranckx P, Valgimigli M. ZEUS Investigators. Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention?: a pre-specified analysis from the ZEUS trial. JACC Cardiovasc Interv. 2016;9(5):426\u201336.","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10400_CR15","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","volume":"373","author":"P Urban","year":"2015","unstructured":"Urban P, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, Lipiecki J, Richardt G, I\u00f1iguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC. LEADERS FREE Investigators. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373(21):2038\u201347.","journal-title":"N Engl J Med"},{"issue":"4","key":"10400_CR16","doi-asserted-by":"publisher","first-page":"e008603","DOI":"10.1161\/CIRCINTERVENTIONS.119.008603","volume":"13","author":"MW Krucoff","year":"2020","unstructured":"Krucoff MW, Urban P, Tanguay JF, McAndrew T, Zhang Y, Rao SV, Morice MC, Price MJ, Cohen DJ, Abdel-Wahab M, Mehta SR, Faurie B, McLaurin B, Diaz C, Stoll HP, Pocock S, Leon MB. Global approach to high bleeding risk patients with polymer-free drug-coated coronary stents. Circ Cardiovasc Interv. 2020;13(4):e008603.","journal-title":"Circ Cardiovasc Interv"},{"issue":"10115","key":"10400_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","volume":"391","author":"O Varenne","year":"2018","unstructured":"Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carri\u00e9 D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S, Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR. SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2018;391(10115):41\u201350.","journal-title":"Lancet"},{"issue":"13","key":"10400_CR18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","volume":"382","author":"S Windecker","year":"2020","unstructured":"Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Hudec M, Poliacikova P, Abdul Ghapar AKB, Selvaraj K, Petrov I, Mylotte D, Pinar E, Moreno R, Fabbiocchi F, Pasupati S, Kim HS, Aminian A, Tie C, Wlodarczak A, Hur SH, Marx SO, Jankovic I, Brar S, Bousquette L, Liu M, Stone GW. ONYX ONE Investigators. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. N Engl J Med. 2020;382(13):1208\u201318.","journal-title":"N Engl J Med"},{"issue":"11","key":"10400_CR19","doi-asserted-by":"publisher","first-page":"e009565","DOI":"10.1161\/CIRCINTERVENTIONS.120.009565","volume":"13","author":"DE Kandzari","year":"2020","unstructured":"Kandzari DE, Kirtane AJ, Windecker S, Latib A, Kedhi E, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Choi JW, Caputo R, Kanitkar M, McLaurin B, Potluri S, Smith T, Spriggs D, Tolleson T, Nazif T, Parke M, Lee LC, Lung TH, Stone GW. Onyx ONE US\/Japan Investigators. One-month dual antiplatelet therapy following percutaneous coronary intervention with zotarolimus-eluting stents in high-bleeding-risk patients. Circ Cardiovasc Interv. 2020;13(11):e009565.","journal-title":"Circ Cardiovasc Interv"},{"issue":"17","key":"10400_CR20","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.jcin.2021.07.016","volume":"14","author":"R Mehran","year":"2021","unstructured":"Mehran R, Cao D, Angiolillo DJ, Bangalore S, Bhatt DL, Ge J, Hermiller J, Makkar RR, Neumann FJ, Saito S, Picon H, Toelg R, Maksoud A, Chehab BM, De la Torre Hernandez JM, Kunadian V, Sardella G, Thiele H, Varenne O, Vranckx P, Windecker S, Zhou Y, Krucoff MW, Ruster K, Wang J, Valgimigli M. XIENCE 90 and XIENCE 28 Investigators. 3- or 1-Month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation. JACC Cardiovasc Interv. 2021;14(17):1870\u201383.","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10400_CR21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","volume":"385","author":"M Valgimigli","year":"2021","unstructured":"Valgimigli M, Frigoli E, Heg D, Tijssen J, J\u00fcni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovi\u0107 G, I\u00f1iguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC. MASTER DAPT Investigators. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021;385(18):1643\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2108749.","journal-title":"N Engl J Med"},{"issue":"21","key":"10400_CR22","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jacc.2021.08.074","volume":"78","author":"M Valgimigli","year":"2021","unstructured":"Valgimigli M, Cao D, Angiolillo DJ, Bangalore S, Bhatt DL, Ge J, Hermiller J, Makkar RR, Neumann FJ, Saito S, Picon H, Toelg R, Maksoud A, Chehab BM, Choi JW, Campo G, De la Torre Hernandez JM, Kunadian V, Sardella G, Thiele H, Varenne O, Vranckx P, Windecker S, Zhou Y, Krucoff MW, Ruster K, Zheng Y, Mehran R. XIENCE 90 and XIENCE 28 Investigators. Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI. J Am Coll Cardiol. 2021;78(21):2060\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10400_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.121.056680","volume":"144","author":"PC Smits","year":"2021","unstructured":"Smits PC, Frigoli E, Tijssen J, J\u00fcni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovic G, I\u00f1iguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Heg D, Valgimigli M. MASTER DAPT Investigators. Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial. Circulation. 2021;144(15):1196\u2013211.","journal-title":"Circulation"},{"issue":"33","key":"10400_CR24","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/eurheartj\/ehac284","volume":"43","author":"M Valgimigli","year":"2022","unstructured":"Valgimigli M, Smits PC, Frigoli E, Bongiovanni D, Tijssen J, Hovasse T, Mafragi A, Ruifrok WT, Karageorgiev D, Aminian A, Garducci S, Merkely B, Routledge H, Ando K, Diaz Fernandez JF, Cuisset T, Nesa Malik FT, Halabi M, Belle L, Din J, Beygui F, Abhyankar A, Reczuch K, Pedrazzini G, Heg D, Vranckx P. MASTER DAPT Investigators. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Eur Heart J. 2022;43(33):3100\u201314.","journal-title":"Eur Heart J"},{"issue":"2","key":"10400_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ccd.27322","volume":"92","author":"MJ Price","year":"2018","unstructured":"Price MJ, Shlofmitz RA, Spriggs DJ, Haldis TA, Myers P, Popma Almonacid A, Maehara A, Dauler M, Peng Y, Mehran R. Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: primary outcome of the RESOLUTE ONYX core trial. Catheter Cardiovasc Interv. 2018;92(2):253\u20139.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-023-10400-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:20:19Z","timestamp":1698668419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-023-10400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10400"],"URL":"https:\/\/doi.org\/10.1007\/s12265-023-10400-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed are in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent is obtained from all patients previous to being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects\/Informed Consent Statement"}},{"value":"R.T. reports lecture honoraria from Biotronik. J.L. reports lecture fees from Astra Zeneca, Biotronik, Medtronic, Berlin-Chemie Menarini, Gedeon Richter, and Sanofi. M.G. reports lecture or consulting fees from BBraun, Terumo, Medtronic, and Amgen. G.G.T. reports grants and\/or personal fees from Biotronik, Medtronic, and Abbott, outside the present work. T.L. reports consulting or lecture fees from Boston Scientific, Medtronic, ABBOTT Vascular, and Novartis. B.H. reports honoraria from Shockwave, Medtronic, and Terumo and consulting fees from Shockwave. B.H. participated as Data Safety Monitoring Board or Advisory Board for Terumo and Microport. J.S. reports the following disclosures during the last 2\u00a0years: consulting fees or lecture fees (AstraZeneca, Bayer HealthCare SAS, CSL Behring SA, Sanofi-Aventis France, and Zoll) and stockholder (4P-Pharma). D.C. reports honoraria from Amgen, Arena, Chiesi, Daiichi Sankyo, Sanofi, and Terumo and institutional fees from Medtronic. G.C. received research grants\/consultant fees\/lectures fees from Amgen, AstraZeneca, Abbott, Bayer, Biotronik, Bristol-Myers Squibb, Edwards, Microport, Medtronic, Pfizer, and Sanofi-Aventis. M.V. reports grants and\/or personal fees from Astra Zeneca, Terumo, Alvimedica\/CID, Abbott Vascular, Daiichi Sankyo, Bayer, CoreFLOW, Idorsia Pharmaceuticals Ltd., Universit\u00e4t Basel Department Klinische Forschung, Vifor, Bristol-Myers-Squib SA, Biotronik, Boston scientific, Medtronic, Vesalio, Novartis, Chiesi, and PhaseBio. The other authors report no relationships relevant to the contents of this paper to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}